Live Breaking News & Updates on Pharmaceutical Trading Down|Page 1

Stay updated with breaking news from Pharmaceutical trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Down 3.6%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report)’s stock price traded down 3.6% on Friday . The stock traded as low as $16.04 and last traded at $16.04. 603 shares traded hands during trading, a decline of 87% from the average session volume of 4,726 shares. The stock had previously closed at $16.64. Ono […] ....

Ono Pharmaceutical Company Profile , Ono Pharmaceutical Co Ltd , Get Free Report , Pharmaceutical Trading Down , Opdivo Intravenous Infusion , Kyprolis Intravenous Injection , Ono Pharmaceutical Daily , Ono Pharmaceutical , Otcmkts Ophlf ,

Caprock Group LLC Decreases Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Caprock Group LLC decreased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 51.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,907 shares of the company’s stock after selling 34,369 shares during the period. Caprock Group […] ....

Legacy Wealth Asset Management , Blue Trust Inc , Caprock Group , Exchange Commission , Takeda Pharmaceutical Company Limited , Bruceg Allen Investments , Securities Exchange Commission , Raymond James Associates , Takeda Pharmaceutical Company , Co Ltd Takeda , Citigroup Inc , Free Report , Takeda Pharmaceutical , Wealth Asset Management , Pharmaceutical Trading Down , Pharmaceutical Company Limited , Get Free Report , Pharmaceutical Co Ltd Takeda , Visit Holdingschannel , Takeda Pharmaceutical Daily , Nyse Tak , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Values First Advisors Inc. Sells 9,642 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Values First Advisors Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,865 shares of the specialty pharmaceutical company’s stock after selling 9,642 shares during the period. […] ....

United States , Scott Dreyer , Piper Sandler , First Advisors Inc , Collegium Pharmaceutical Inc , Financial Services Group Inc , Securities Exchange Commission , American Century Companies Inc , Jefferies Financial Group , Needham Company , Envestnet Asset Management Inc , Citigroup Inc , Values First Advisors , Collegium Pharmaceutical , Free Report , First Advisors , Asset Management , Century Companies , Services Group , Montreal Can , Pharmaceutical Trading Down , Get Free Report , Exchange Commission , Financial Group , Visit Holdingschannel , Collegium Pharmaceutical Daily ,